Seelos Therapeutics

Manufacturing · New York, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

300 Park Ave Fl 2, New York, New York, 1...

Phone Number

(646) 293-2100

Revenue

$29.8 Million

Stock Symbol

SEEL

Industry

Manufacturing Pharmaceuticals

About Seelos Therapeutics

Seelos Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for central nervous system (CNS) disorders and rare diseases. Their product pipeline includes treatments such as SLS-002 for acute suicidal ideation in major depressive disorder and PTSD, SLS-004 gene therapy, and SLS-005 intravenous trehalose. The company aims to address significant unmet medical needs and improve patient outcomes. Their intended clients include patients suffering from severe mental health conditions and rare diseases, as well as caregivers and healthcare providers.Explore more
Seelos Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: SEELShow more

Seelos Therapeutics Org Chart

PhoneEmail
MG
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Seelos Therapeutics

Compare insights from companies similar to Seelos Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Seelos Therapeutics

$29.8M
1-10
Public
$65.5M
2016
MG
Michael GolembiewskiChief Financial Officer
<$5M
11-50
Private
<$5M
2003
KB
Kacie BlackSPM Clinic Manager
<$5M
11-50
Private
-
1982
<$5M
1-10
Public
$8.4M
2012
GG
Gerald GoodmanChief Financial Officer
<$5M
11-50
Private
<$5M
2008
RF
Russell FlymenVice President, Operations
<$5M
1-10
Private
<$5M
2012
Illustration of an envelope

Seelos Therapeutics Tech Stack

A closer look at the technologies used by Seelos Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Seelos Therapeutics

What is Seelos Therapeutics's stock symbol?
Seelos Therapeutics's stock symbol is SEEL
What is Seelos Therapeutics's official website?
Seelos Therapeutics's official website is www.seelostherapeutics.com
What is Seelos Therapeutics's Revenue?
Seelos Therapeutics's revenue is $29.8 Million
What is Seelos Therapeutics's SIC code?
Seelos Therapeutics's SIC: 28,283
What is Seelos Therapeutics's NAICS code?
Seelos Therapeutics's NAICS: 32,325
How many employees does Seelos Therapeutics have?
Seelos Therapeutics has 1-10 employees
What industry does Seelos Therapeutics belong to?
Seelos Therapeutics is in the industry of: Manufacturing, Pharmaceuticals
What is Seelos Therapeutics competition?
Seelos Therapeutics top competitors include: Kamat Pharmatech, Nutriband, MacroChem, Promescent
What companies has Seelos Therapeutics acquired?
Seelos Therapeutics has acquired the companies: TopoTarget USA
What technology does Seelos Therapeutics use?
Some of the popular technologies that Seelos Therapeutics uses are: WordPress.org, Bullhorn, MailChimp, Proofpoint
Who is the CFO of Seelos Therapeutics?
Seelos Therapeutics's CFO is Michael Golembiewski
How do I contact Seelos Therapeutics?
Seelos Therapeutics contact info: Phone number: (646) 293-2100 Website: www.seelostherapeutics.com
What does Seelos Therapeutics do?

Seelos Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for central nervous system (CNS) disorders and rare diseases. Their product pipeline includes treatments such as SLS-002 for acute suicidal ideation in major depressive disorder and PTSD, SLS-004 gene therapy, and SLS-005 intravenous treha... lose. The company aims to address significant unmet medical needs and improve patient outcomes. Their intended clients include patients suffering from severe mental health conditions and rare diseases, as well as caregivers and healthcare providers.Read More

What are Seelos Therapeutics social media links?
Seelos Therapeutics Linkedin page Seelos Therapeutics Twitter page
Who invested in Seelos Therapeutics?
Seelos Therapeutics has 4 investors including Lind Global Asset Management V, LLC, The Lind Partners LLC and Team Sanfilippo Foundation.
Is Seelos Therapeutics a public company?
Yes, Seelos Therapeutics is a public company and is traded under the symbol SEEL
See more information about Seelos Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.